4.2 Article

COVERAGE WITH EVIDENCE DEVELOPMENT FOR PHARMACEUTICALS: A POLICY IN EVOLUTION?

Related references

Note: Only part of the references are listed.
Article Health Care Sciences & Services

Published randomized controlled trials of drug therapy for dementia often lack complete data on harm

P. E. Lee et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2008)

Article Medicine, General & Internal

Selective publication of antidepressant trials and its influence on apparent efficacy

Erick H. Turner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Article Health Care Sciences & Services

Coverage with evidence development: An examination of conceptual and policy issues

John Hutton et al.

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2007)

Review Medicine, General & Internal

Eligibility criteria of randomized controlled trials published in high-impact general medical journals - A systematic sampling review

Harriette G. C. Van Spall et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

Article Health Care Sciences & Services

Coverage options for promising technologies: Medicare's 'coverage with evidence development'

Sean R. Tunis et al.

HEALTH AFFAIRS (2006)

Article Health Care Sciences & Services

Medicare's coverage of colorectal cancer drugs: A case study in evidence development and policy

Tanisha Carino et al.

HEALTH AFFAIRS (2006)

Article Medicine, General & Internal

Practical clinical trials - Increasing the value of clinical research for decision making in clinical and health policy

SR Tunis et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)